Quanterix (QTRX) Income from Continuing Operations (2017 - 2026)
Quanterix's (QTRX) quarterly Income from Continuing Operations came in at 17541000.0 in Q1 2026, up 14.45% YoY from 15326231.05 in Q1 2025, and up 24.12% on a QoQ basis from 23117000.0 in Q4 2025.
Quanterix (QTRX) Income from Continuing Operations (2017 - 2026) Analysis & Trends
Quanterix (QTRX) has 10 years of Income from Continuing Operations data on file, last reported at 17541000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 14.45% year-over-year to 17541000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 104188000.0 (down 117.64% YoY) and the FY2025 annual result came in at 107150000.0, down 178.09% from the prior year.
- Income from Continuing Operations advanced to 17541000.0 in Q1 2026, from 23117000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 5551000.0 in Q2 2023 to a low of 36550000.0 in Q3 2022.
- A 5-year average of 17126529.41 and a median of 17541000.0 in 2026 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations jumped 81.63% — and 2025, when it tumbled 306.29%.
- Tracing QTRX's Income from Continuing Operations over 5 years: stood at 18198000.0 in 2022, then soared by 51.57% to 8813000.0 in 2023, then plunged by 31.94% to 11628000.0 in 2024, then plunged by 98.8% to 23117000.0 in 2025, then rose by 24.12% to 17541000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 17541000.0 (Q1 2026), 23117000.0 (Q4 2025), and 33517000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Quanterix | 148.34 Mn | 54.81 Mn | 12.67 Mn | -48.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -48.93 Mn |
| Mar 31, 2026 | -17.54 Mn |
| Dec 31, 2025 | -23.12 Mn |
| Sep 30, 2025 | -33.52 Mn |
| Jun 30, 2025 | -30.01 Mn |
| Mar 31, 2025 | -20.50 Mn |
| Dec 31, 2024 | -11.63 Mn |
| Sep 30, 2024 | -8.35 Mn |
| Jun 30, 2024 | -7.39 Mn |
| Mar 31, 2024 | -11.16 Mn |
| Dec 31, 2023 | -8.81 Mn |
| Sep 30, 2023 | -6.72 Mn |
| Jun 30, 2023 | -5.55 Mn |
| Mar 31, 2023 | -7.27 Mn |
| Dec 31, 2022 | -18.20 Mn |
| Sep 30, 2022 | -36.55 Mn |
| Jun 30, 2022 | -26.91 Mn |
| Mar 31, 2022 | -17.92 Mn |
| Dec 31, 2021 | -17.89 Mn |
| Sep 30, 2021 | -15.66 Mn |